Ubiquitin, Ubiquitinylation, Unfolded Protein Response (UPR), tagged Artificial intelligence, biotech startup, early ventures, Machine Learning, philadelphia, PROTAC, Proteovant, Therapeutic innovations, ubiquitin-proteosome, University of Michigan, Venture capital on October 26, 2021| Leave a Comment ...
“We believe this is going to be the next rendition of how we can train physicians, as well as make surgeons more effective at their job,” says Nitin K. Yerram, MD. Dr. Basralian on the current state of focal therapy in prostate cancer ...